These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 29199877)

  • 21. Transvascular Hydrolysis of Hyaluronic Acid Filler With Hyaluronidase: An Ex Vivo Study.
    Rauso R; Zerbinati N; Fragola R; Nicoletti GF; Tartaro G
    Dermatol Surg; 2021 Mar; 47(3):370-372. PubMed ID: 32932270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Effectiveness of Different Interventions of Perivascular Hyaluronidase.
    Lee W; Oh W; Oh SM; Yang EJ
    Plast Reconstr Surg; 2020 Apr; 145(4):957-964. PubMed ID: 32221213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of Visual Loss With Retrobulbar Hyaluronidase Injection After Hyaluronic Acid Filler.
    Chesnut C
    Dermatol Surg; 2018 Mar; 44(3):435-437. PubMed ID: 28877147
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of Percutaneous Intraarterial Facial/Supratrochlear Arterial Hyaluronidase Injection for Treatment of Vascular Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.
    Zheng C; Fu Q; Zhou GW; Lai LY; Zhang LX; Zhang DQ; Chen GJ; Liang LM; Chen ML
    Aesthet Surg J; 2022 May; 42(6):649-655. PubMed ID: 34958671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soft-Tissue Infection Caused by Streptococcus anginosus After Intramucosal Hyaluronidase Injection: A Rare Complication Related to Dermal Filler Injection.
    Rivers JK; Mistry BD
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S51-S53. PubMed ID: 30106761
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing Retrobulbar Hyaluronidase as a Treatment for Filler-Induced Blindness in a Cadaver Model.
    Paap MK; Milman T; Ugradar S; Silkiss RZ
    Plast Reconstr Surg; 2019 Aug; 144(2):315-320. PubMed ID: 31348334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial degradation of hyaluronic acid filler by hyaluronidase.
    DeLorenzi C
    Dermatol Surg; 2014 Aug; 40(8):832-41. PubMed ID: 25022707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.
    Buhren BA; Schrumpf H; Bölke E; Kammers K; Gerber PA
    Eur J Med Res; 2018 Aug; 23(1):37. PubMed ID: 30122153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.
    Ryu C; Lu JE; Zhang-Nunes S
    J Plast Reconstr Aesthet Surg; 2021 Apr; 74(4):881-889. PubMed ID: 33308988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durability, Behavior, and Tolerability of 5 Hyaluronidase Products.
    Casabona G; Marchese PB; Montes JR; Hornfeldt CS
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S42-S50. PubMed ID: 29894436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronidase offers an efficacious treatment for inaesthetic hyaluronic acid overcorrection.
    Pierre A; Levy PM
    J Cosmet Dermatol; 2007 Sep; 6(3):159-62. PubMed ID: 17760692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Intra-arterial Hyaluronidase Injection for Hyaluronic Acid Filler Embolism Threatening Skin Barrier Integrity: Implementation of a Stepwise Treatment Protocol.
    Fu Q; Zheng C; Zhou GW; Xu X; Lai LY; Sun XE; Zhang LX; Wu Q; Ding HF; Yang Y; Fu HJ; Chen ML
    Aesthetic Plast Surg; 2024 Feb; 48(4):747-751. PubMed ID: 37775575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the In Vivo Kinetics and Biostimulatory Effects of Subcutaneously Injected Hyaluronic Acid Filler.
    Mochizuki M; Aoi N; Gonda K; Hirabayashi S; Komuro Y
    Plast Reconstr Surg; 2018 Jul; 142(1):112-121. PubMed ID: 29952893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of noninflammatory nodule in chin after a large volume bolus injection of hyaluronic acid filler.
    Saputra DI; Kapoor KM
    Dermatol Ther; 2020 May; 33(3):e13424. PubMed ID: 32307855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An adverse reaction after hyaluronic acid filler application: a case report.
    Vidič M; Bartenjev I
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Sep; 27(3):165-167. PubMed ID: 30244271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro.
    Faivre J; Wu K; Gallet M; Sparrow J; Bourdon F; Gallagher CJ
    Aesthet Surg J; 2024 May; 44(6):NP402-NP410. PubMed ID: 38366708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin Remodeling Using Hyaluronic Acid Filler Injections in Photo-Aged Faces.
    França Wanick FB; Almeida Issa MC; Luiz RR; Soares Filho PJ; Olej B
    Dermatol Surg; 2016 Mar; 42(3):352-9. PubMed ID: 26918965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic oculomotor nerve palsy due to hyaluronic acid filler injection.
    Bae IH; Kim MS; Choi H; Na CH; Shin BS
    J Cosmet Dermatol; 2018 Dec; 17(6):1016-1018. PubMed ID: 29607622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergic reaction to hyaluronidase use after hyaluronic acid filler injection.
    Kim MS; Youn S; Na CH; Shin BS
    J Cosmet Laser Ther; 2015; 17(5):283-5. PubMed ID: 25588036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
    Zhang L; Feng X; Shi H; Wu WTL; Wu S
    Aesthet Surg J; 2020 Feb; 40(3):319-326. PubMed ID: 31630161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.